← The Wire
BNTCNasdaq
Benitec Biopharma Inc.
Pharmaceutical Preparations · DE · CIK 1808898
Benitec Biopharma develops genetic medicines using a "silence and replace" approach to treat genetic disorders
red 8-K · 90d
$384M
Market cap
$12.70
Last close
+2.7%
1D
+3.3%
5D
98K
Volume
Price · last 39 sessions+4.3%
May 4L $10.39 · H $13.63Jun 29
154
Total filings
May 29, 2026
Last filing
06/30
Fiscal year end
8-KExecutive ChangeMay 29, 202610-Q10-QMay 14, 20268-KResults of OperationsMay 14, 202610-K/A10-K/AMar 20, 20268-KResults of OperationsFeb 12, 202610-Q10-QFeb 12, 20268-KShareholder VoteDec 2, 20258-KResults of OperationsNov 14, 202510-Q10-QNov 14, 2025DEFA14ADEFA14ANov 12, 20258-KMaterial Agreement · Company UpdateNov 7, 2025424B5424B5Nov 7, 2025424B5424B5Nov 5, 20258-KExecutive Change · Reg FD DisclosureNov 3, 2025DEFA14ADEFA14AOct 14, 2025DEF 14ADEF 14AOct 14, 20258-KResults of OperationsSep 22, 202510-K10-KSep 22, 20258-KRestatementSep 12, 20258-KReg FD DisclosureJul 9, 20258-KResults of OperationsMay 14, 202510-Q10-QMay 14, 20258-KCompany UpdateMar 28, 20258-KMaterial AgreementMar 27, 2025424B5424B5Mar 26, 20258-KMaterial Agreement · Company UpdateMar 26, 20258-KCompany UpdateMar 20, 20258-KReg FD DisclosureMar 19, 20258-KResults of OperationsFeb 14, 202510-QFORM 10-QFeb 14, 20258-K/AExecutive ChangeDec 31, 20248-KExecutive ChangeDec 13, 20248-KSecurity-Holder Rights · Bylaw AmendmentDec 10, 20248-KShareholder VoteDec 6, 20248-KResults of OperationsNov 14, 2024DEFA14ADEFA14ANov 14, 202410-QFORM 10-QNov 14, 20248-KExecutive ChangeNov 14, 2024DEF 14ADEF 14AOct 22, 2024DEFA14ADEFA14AOct 22, 20248-KReg FD DisclosureOct 15, 2024424B5424B5Oct 15, 2024424B5424B5Oct 11, 20248-KMaterial AgreementOct 11, 20248-KCompany UpdateOct 8, 20248-KResults of OperationsSep 26, 202410-K10-KSep 26, 20248-KExecutive Change · Shareholder VoteSep 5, 2024DEF 14ADEF 14AJul 29, 20248-KReg FD DisclosureJul 15, 20248-KExecutive ChangeJul 1, 2024S-1S-1May 16, 20248-KResults of OperationsMay 13, 202410-QFORM 10-QMay 13, 2024SC 13DSCHEDULE 13DApr 29, 2024SC 13GSC 13GApr 29, 2024SC 13GSC 13GApr 29, 20248-KMaterial Agreement · Equity IssuanceApr 19, 20248-KReg FD DisclosureApr 18, 20248-KExecutive ChangeMar 8, 20248-KResults of OperationsFeb 13, 202410-QFORM 10-QFeb 13, 20248-KExecutive Change · Shareholder VoteDec 7, 20238-KReg FD DisclosureNov 30, 20238-KResults of OperationsNov 13, 202310-QFORM 10-QNov 13, 2023DEFA14ADEFA14AOct 20, 2023DEF 14ADEF 14AOct 20, 20238-KExecutive ChangeOct 16, 20238-KCompany UpdateSep 28, 20238-KResults of OperationsSep 21, 202310-K10-KSep 21, 20238-KExecutive ChangeSep 18, 2023SC 13GBENITEC BIOPHARMA INC.Aug 25, 2023SC 13GSC 13GAug 21, 20238-KMaterial Agreement · Company UpdateAug 11, 20238-KDelisting NoticeAug 10, 2023424B4424B4Aug 10, 2023S-1/AS-1/AAug 7, 2023S-1/AS-1/AAug 3, 2023
Insider Activity
◆ Cluster Buy · 3 insidersIn the 90 days to Dec 29, 2025: 3 insiders bought $22.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 29, 2025 | Cowen AaronDirector,TenPercentOwner | Buy | 65,800 | $13.44 | $884K |
| Dec 29, 2025 | Cowen AaronDirector,TenPercentOwner | Buy | 11,587 | $13.44 | $156K |
| Dec 26, 2025 | Cowen AaronDirector,TenPercentOwner | Buy | 14,320 | $13.10 | $188K |
| Dec 26, 2025 | Cowen AaronDirector,TenPercentOwner | Buy | 2,516 | $13.10 | $33K |
| Dec 23, 2025 | Cowen AaronDirector,TenPercentOwner | Buy | 42,600 | $12.85 | $547K |
| Dec 23, 2025 | Cowen AaronDirector,TenPercentOwner | Buy | 7,400 | $12.85 | $95K |
| Dec 22, 2025 | Averill Madison Master Fund, Ltd.TenPercentOwner | Buy | 16,650 | $12.08 | $201K |
| Dec 22, 2025 | Averill Madison Master Fund, Ltd.TenPercentOwner | Buy | 2,892 | $12.08 | $35K |
| Dec 19, 2025 | Averill Madison Master Fund, Ltd.TenPercentOwner | Buy | 13,950 | $11.48 | $160K |
| Dec 19, 2025 | Averill Madison Master Fund, Ltd.TenPercentOwner | Buy | 2,434 | $11.48 | $28K |
| Dec 18, 2025 | Averill Madison Master Fund, Ltd.TenPercentOwner | Buy | 8,700 | $11.24 | $98K |
| Dec 18, 2025 | Averill Madison Master Fund, Ltd.TenPercentOwner | Buy | 1,515 | $11.24 | $17K |
| Nov 7, 2025 | Suvretta Capital Management, LlcDirector,TenPercentOwner | Buy | 751,111 | $13.50 | $10.1M |
| Nov 7, 2025 | Suvretta Capital Management, LlcDirector,TenPercentOwner | Buy | 730,370 | $13.50 | $9.9M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance